Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAENNEC in Chronic Liver Disease
NCT05532124Phase 2Completed
- Sponsor
- GC Wellbeing
- Start
- Jun 2021
- Primary completion
- May 2023
- Countries
- 1
01
Overview
A Phase 2 trial of LAENNEC in chronic liver disease (CLD), sponsored by GC Wellbeing. Started Jun 2021; status: completed.
02
Drugs
LAENNEC
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT05532124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05532124.